| Literature DB >> 34389214 |
Justin Komguep Nono1, Severin Donald Kamdem2, Fungai Musaigwa3, Chukwudi A Nnaji4, Frank Brombacher5.
Abstract
Schistosomiasis is a debilitating helminthiasis which commonly establishes as a chronic infection in people from endemic areas. As a potent modulator of the host immune response, the Schistosoma parasite and its associated products can directly interfere with its host's ability to mount adequate immune responses to unrelated antigens. As a result, increased attention is gathering on studies assessing the influence of helminths, particularly the causal agent of schistosomiasis, on host responsiveness to vaccines. However, to date, no consensus has been drawn regarding the influence of schistosomiasis on host vaccine responses. Here, we review available evidence on the influence of transgenerational and direct Schistosoma parasite exposure on host immune responses to unrelated vaccines. In addition, we evaluate the potential of praziquantel (PZQ) treatment in restoring schistosomiasis-impacted vaccine responses.Entities:
Keywords: human; immunomodulation; praziquantel (PZQ); schistosomiasis; vaccine response
Mesh:
Substances:
Year: 2021 PMID: 34389214 DOI: 10.1016/j.pt.2021.07.009
Source DB: PubMed Journal: Trends Parasitol ISSN: 1471-4922